Context: Maternal adiposity in pregnancy is associated with offspring adiposity and metabolic dysfunction postnatally, including greater risk of non-alcoholic fatty liver disease (NAFLD). Recent genetic analyses suggest a causal effect of greater maternal body mass index on offspring birthweight and ponderal index but the relative roles of the environment in-utero or later in life remains unclear. Objective: We sought to determine whether markers of infant adiposity (birthweight, umbilical cord blood leptin, adiponectin and lipids) were associated with markers of NAFLD in adolescence. Design, setting and participants: UK prospective birth cohort with 17 years of follow-up with liver function tests (AST, ALT, GGT) (n=1037 participants),...
Objective Nonalcoholic fatty liver disease (NAFLD) is a well-recognized hepatic manifestation of met...
First published March 18, 2015Greater adiposity is an important risk factor for nonalcoholic fatty l...
Abstract Background Priming for cardiometabolic diseases, including non-alcoholic fatty liver diseas...
© 2016 by the Endocrine Society. Context: Maternal adiposity in pregnancy is associated with offspri...
© 2016 by the Endocrine Society. Context: Maternal adiposity in pregnancy is associated with offspri...
Background: Little is known about early life determinants of non-alcoholic fatty liver disease (NAF...
Background: Little is known about early life determinants of non-alcoholic fatty liver disease (NAF...
Background: Little is known about early life determinants of non-alcoholic fatty liver disease (NAFL...
Context: Exposure to maternal adiposity during pregnancy is associated with higher offspring birthw...
Background & Aims: The pathway to non-alcoholic fatty liver disease (NAFLD) in adolescents may have ...
Background & Aims: The pathway to non-alcoholic fatty liver disease (NAFLD) in adolescents may have ...
Background and Aims: Adiposity is a key risk factor for NAFLD. Few studies have examined prospectiv...
Background & Aims: The pathway to non-alcoholic fatty liver disease (NAFLD) in adolescents may have ...
Background & AimsAdiposity is a key risk factor for NAFLD. Few studies have examined prospective ass...
Background & Aims: The pathway to non-alcoholic fatty liver disease (NAFLD) in adolescents may have ...
Objective Nonalcoholic fatty liver disease (NAFLD) is a well-recognized hepatic manifestation of met...
First published March 18, 2015Greater adiposity is an important risk factor for nonalcoholic fatty l...
Abstract Background Priming for cardiometabolic diseases, including non-alcoholic fatty liver diseas...
© 2016 by the Endocrine Society. Context: Maternal adiposity in pregnancy is associated with offspri...
© 2016 by the Endocrine Society. Context: Maternal adiposity in pregnancy is associated with offspri...
Background: Little is known about early life determinants of non-alcoholic fatty liver disease (NAF...
Background: Little is known about early life determinants of non-alcoholic fatty liver disease (NAF...
Background: Little is known about early life determinants of non-alcoholic fatty liver disease (NAFL...
Context: Exposure to maternal adiposity during pregnancy is associated with higher offspring birthw...
Background & Aims: The pathway to non-alcoholic fatty liver disease (NAFLD) in adolescents may have ...
Background & Aims: The pathway to non-alcoholic fatty liver disease (NAFLD) in adolescents may have ...
Background and Aims: Adiposity is a key risk factor for NAFLD. Few studies have examined prospectiv...
Background & Aims: The pathway to non-alcoholic fatty liver disease (NAFLD) in adolescents may have ...
Background & AimsAdiposity is a key risk factor for NAFLD. Few studies have examined prospective ass...
Background & Aims: The pathway to non-alcoholic fatty liver disease (NAFLD) in adolescents may have ...
Objective Nonalcoholic fatty liver disease (NAFLD) is a well-recognized hepatic manifestation of met...
First published March 18, 2015Greater adiposity is an important risk factor for nonalcoholic fatty l...
Abstract Background Priming for cardiometabolic diseases, including non-alcoholic fatty liver diseas...